<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dvorak J</submitter><funding>European Regional Development Fund-Project "UP CIISB "</funding><funding>Czech Academy of Sciences</funding><funding>MEYS CR</funding><funding>Charles University Grant Agency</funding><funding>Medical Research Foundation of the Czech Republic</funding><funding>European Regional Development Fund-Project &amp;quot;UP CIISB &amp;quot;</funding><funding>National Recovery Plan</funding><pagination>20</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10176672</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Sepsis is a common worldwide health condition with high mortality. It is caused by a dysregulated immune response to the pathogen. Severe infections resulting in sepsis can be also determined by monitoring several bloodstream biomarkers, one of them being pro-hormone procalcitonin (PCT). PCT concentration in the bloodstream correlates well with sepsis and in severe cases increases up to a thousand times from the healthy physiological values in a short time. In this study, we developed a rapid technique for PCT detection by MALDI-TOF mass spectrometry, that uses in-situ enrichment directly on the specialized immuno MALDI chips that are utilized as MALDI plates. The method's ability to detect PCT was confirmed by comparing the results with LC-MS bottom-up workflow. The new</pubmed_abstract><journal>Clinical proteomics</journal><pubmed_title>The rapid detection of procalcitonin in septic serum using immunoaffinity MALDI chips.</pubmed_title><pmcid>PMC10176672</pmcid><funding_grant_id>384021</funding_grant_id><funding_grant_id>RVO61388971</funding_grant_id><funding_grant_id>LX22NPO5103</funding_grant_id><funding_grant_id>LM2018127</funding_grant_id><funding_grant_id>CZ.02.1.01/0.0/0.0/18_046/0015974</funding_grant_id><funding_grant_id>NV19-05-00541</funding_grant_id><pubmed_authors>Horak J</pubmed_authors><pubmed_authors>Dvorak J</pubmed_authors><pubmed_authors>Pompach P</pubmed_authors><pubmed_authors>Karvunidis T</pubmed_authors><pubmed_authors>Kralovcova M</pubmed_authors><pubmed_authors>Hrabak J</pubmed_authors><pubmed_authors>Volny M</pubmed_authors><pubmed_authors>Kraftova L</pubmed_authors><pubmed_authors>Radej J</pubmed_authors><pubmed_authors>Novak P</pubmed_authors><pubmed_authors>Matejovic M</pubmed_authors><pubmed_authors>Novakova J</pubmed_authors><pubmed_authors>Kalaninova Z</pubmed_authors><pubmed_authors>Studentova V</pubmed_authors></additional><is_claimable>false</is_claimable><name>The rapid detection of procalcitonin in septic serum using immunoaffinity MALDI chips.</name><description>&lt;h4>Background&lt;/h4>Sepsis is a common worldwide health condition with high mortality. It is caused by a dysregulated immune response to the pathogen. Severe infections resulting in sepsis can be also determined by monitoring several bloodstream biomarkers, one of them being pro-hormone procalcitonin (PCT). PCT concentration in the bloodstream correlates well with sepsis and in severe cases increases up to a thousand times from the healthy physiological values in a short time. In this study, we developed a rapid technique for PCT detection by MALDI-TOF mass spectrometry, that uses in-situ enrichment directly on the specialized immuno MALDI chips that are utilized as MALDI plates. The method's ability to detect PCT was confirmed by comparing the results with LC-MS bottom-up workflow. The new</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-05-15T03:17:39.333Z</modification><creation>2025-02-19T02:23:05.727Z</creation></dates><accession>S-EPMC10176672</accession><cross_references><pubmed>37170190</pubmed><doi>10.1186/s12014-023-09410-3</doi></cross_references></HashMap>